Fengjie Qiao, Yan Xue, Chen Zou, Kun Liu, Jie Yuan, Longshan Ji, Lingying Huang, Man Li, Yueqiu Gao
{"title":"不同肝叶MRI-PDFF检出值在肝脂肪变性诊断中的应用性能。","authors":"Fengjie Qiao, Yan Xue, Chen Zou, Kun Liu, Jie Yuan, Longshan Ji, Lingying Huang, Man Li, Yueqiu Gao","doi":"10.1007/s10238-025-01739-3","DOIUrl":null,"url":null,"abstract":"<p><p>Magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) is becoming increasingly important for assessing liver steatosis, which is traditionally diagnosed via liver biopsy. In the present study, we aimed to evaluate the efficacy of MRI-PDFF in detecting liver steatosis by comparing its values from various liver lobes-the right posterior hepatic lobe (RPHL), right anterior hepatic lobe (RAHL), left inner hepatic lobe (LIHL), left outer hepatic lobe (LOHL), the mean value of four hepatic lobes (M-PDFF), and the highest value of four hepatic lobes (H-PDFF)-against biopsy results. The findings indicated that MRI-PDFF exhibited strong performances in identifying liver steatosis in 125 patients, with area under the receiver operating characteristic (AUROC) values of 0.870 for RPHL, 0.875 for RAHL, 0.881 for LIHL, 0.871 for LOHL, 0.881 for M-PDFF, and 0.878 for H-PDFF. Furthermore, MRI-PDFF demonstrated significant advantages in detecting moderate-to-severe steatosis, achieving AUROC values of 0.897 for RPHL, 0.911 for RAHL, 0.905 for LIHL, 0.898 for LOHL, 0.907 for M-PDFF, and 0.904 for H-PDFF. Overall, MRI-PDFF is a highly accurate and noninvasive tool for diagnosing liver steatosis and determining its severity, making it valuable for clinical assessment and treatment.</p>","PeriodicalId":10337,"journal":{"name":"Clinical and Experimental Medicine","volume":"25 1","pages":"210"},"PeriodicalIF":3.5000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176965/pdf/","citationCount":"0","resultStr":"{\"title\":\"The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosis.\",\"authors\":\"Fengjie Qiao, Yan Xue, Chen Zou, Kun Liu, Jie Yuan, Longshan Ji, Lingying Huang, Man Li, Yueqiu Gao\",\"doi\":\"10.1007/s10238-025-01739-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) is becoming increasingly important for assessing liver steatosis, which is traditionally diagnosed via liver biopsy. In the present study, we aimed to evaluate the efficacy of MRI-PDFF in detecting liver steatosis by comparing its values from various liver lobes-the right posterior hepatic lobe (RPHL), right anterior hepatic lobe (RAHL), left inner hepatic lobe (LIHL), left outer hepatic lobe (LOHL), the mean value of four hepatic lobes (M-PDFF), and the highest value of four hepatic lobes (H-PDFF)-against biopsy results. The findings indicated that MRI-PDFF exhibited strong performances in identifying liver steatosis in 125 patients, with area under the receiver operating characteristic (AUROC) values of 0.870 for RPHL, 0.875 for RAHL, 0.881 for LIHL, 0.871 for LOHL, 0.881 for M-PDFF, and 0.878 for H-PDFF. Furthermore, MRI-PDFF demonstrated significant advantages in detecting moderate-to-severe steatosis, achieving AUROC values of 0.897 for RPHL, 0.911 for RAHL, 0.905 for LIHL, 0.898 for LOHL, 0.907 for M-PDFF, and 0.904 for H-PDFF. Overall, MRI-PDFF is a highly accurate and noninvasive tool for diagnosing liver steatosis and determining its severity, making it valuable for clinical assessment and treatment.</p>\",\"PeriodicalId\":10337,\"journal\":{\"name\":\"Clinical and Experimental Medicine\",\"volume\":\"25 1\",\"pages\":\"210\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176965/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10238-025-01739-3\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10238-025-01739-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosis.
Magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) is becoming increasingly important for assessing liver steatosis, which is traditionally diagnosed via liver biopsy. In the present study, we aimed to evaluate the efficacy of MRI-PDFF in detecting liver steatosis by comparing its values from various liver lobes-the right posterior hepatic lobe (RPHL), right anterior hepatic lobe (RAHL), left inner hepatic lobe (LIHL), left outer hepatic lobe (LOHL), the mean value of four hepatic lobes (M-PDFF), and the highest value of four hepatic lobes (H-PDFF)-against biopsy results. The findings indicated that MRI-PDFF exhibited strong performances in identifying liver steatosis in 125 patients, with area under the receiver operating characteristic (AUROC) values of 0.870 for RPHL, 0.875 for RAHL, 0.881 for LIHL, 0.871 for LOHL, 0.881 for M-PDFF, and 0.878 for H-PDFF. Furthermore, MRI-PDFF demonstrated significant advantages in detecting moderate-to-severe steatosis, achieving AUROC values of 0.897 for RPHL, 0.911 for RAHL, 0.905 for LIHL, 0.898 for LOHL, 0.907 for M-PDFF, and 0.904 for H-PDFF. Overall, MRI-PDFF is a highly accurate and noninvasive tool for diagnosing liver steatosis and determining its severity, making it valuable for clinical assessment and treatment.
期刊介绍:
Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.